{
  "id": 2113246,
  "title": "Mankind Pharma Licenses Two Insulin Products, Expands Diabetes Portfolio",
  "url": "https://urgent.news/2026/08/20/mankind-pharma-licenses-two-insulin-products-expands-diabetes",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T09:37:54.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/mankind-pharma-licenses-two-insulin-products-expands-diabetes-portfolio"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Mankind Pharma has entered into an exclusive in-licensing and marketing agreement with China-based Chongqing Chenan Biopharmaceutical for two insulin products in India. The agreement covers Insulin Degludec and a combination of Insulin Degludec and Insulin Aspart. Mankind Pharma will commercialise both injectable treatments in the Indian market. Diabetes portfolio expands The partnership…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}